| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.041 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |